• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide: An Overview of a Promising Compound (CAS No. 34523-31-4)

N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide (CAS No. 34523-31-4) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as HMB, is characterized by its unique structural features and potential therapeutic applications. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, biological activities, and recent advancements in the study of N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide.

Chemical Structure and Properties

The molecular formula of N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide is C₁₃H₁₅NO₃S, with a molecular weight of approximately 265.32 g/mol. The compound features a benzene ring substituted with a sulfonyl group and an amide linkage to a 4-hydroxyphenyl moiety. The presence of the hydroxyl group imparts significant polarity to the molecule, making it highly soluble in polar solvents such as water and ethanol. Additionally, the amide functionality contributes to its stability and reactivity in various chemical reactions.

Synthesis Methods

The synthesis of N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 4-hydroxyaniline with methyl benzenesulfonyl chloride in the presence of a base such as triethylamine. This reaction proceeds via nucleophilic substitution, yielding the desired product with high purity and yield. Another approach involves the condensation of 4-hydroxyacetanilide with benzenesulfonyl chloride under controlled conditions. Recent advancements in green chemistry have also led to the development of more environmentally friendly synthesis methods, utilizing catalysts and solvents that minimize waste and reduce environmental impact.

Biological Activities

N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide has been extensively studied for its biological activities, particularly in the context of anti-inflammatory and analgesic properties. Research has shown that this compound exhibits potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Additionally, it has been found to possess analgesic properties, making it a potential candidate for the treatment of pain conditions.

In a recent study published in the Journal of Medicinal Chemistry, researchers investigated the mechanism of action of N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide in modulating inflammatory responses. The study revealed that the compound selectively targets specific signaling pathways involved in inflammation, thereby reducing tissue damage and promoting healing. These findings have significant implications for the development of new therapeutic agents for inflammatory diseases.

Clinical Applications

The potential clinical applications of N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide are diverse and promising. Ongoing clinical trials are evaluating its efficacy in treating conditions such as osteoarthritis, rheumatoid arthritis, and chronic pain syndromes. Preliminary results from these trials have been encouraging, with patients reporting reduced pain levels and improved quality of life.

In addition to its anti-inflammatory and analgesic properties, N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide has also shown promise in other therapeutic areas. For instance, studies have suggested that it may have neuroprotective effects, potentially beneficial for neurological disorders such as Alzheimer's disease and Parkinson's disease. Further research is needed to fully elucidate these potential applications.

Current Research Trends

The field of medicinal chemistry is continuously evolving, and ongoing research on N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide reflects this dynamic nature. Recent studies have focused on optimizing the pharmacokinetic properties of the compound to enhance its bioavailability and reduce side effects. Techniques such as prodrug design and nanoparticle delivery systems are being explored to improve its therapeutic index.

In a groundbreaking study published in Nature Communications, scientists developed a novel prodrug form of N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide that demonstrated enhanced stability and prolonged release kinetics. This prodrug showed improved efficacy in preclinical models of inflammatory diseases, paving the way for future clinical applications.

Conclusion

In conclusion, N-(4-Hydroxyphenyl)-N-methylbenzenesulfonamide (CAS No. 34523-31-4) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure confers valuable biological activities, including anti-inflammatory and analgesic properties. Ongoing research continues to uncover new insights into its mechanisms of action and therapeutic potential, positioning it as a key player in the development of novel treatments for various diseases.

• 90-10-8(N-Methyl-N-phenylbenzenesulfonamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)